Irreversible myelosuppression after fludarabine-melphalan conditioning: observations in patients with graft rejection.

Overview

authors

Van Besien, Koen
Smith, Sonali
Anastasi, John
Larson, Richard
Thirman, Michael
Odenike, Toyosi
Stock, Wendy

publication date

June 1, 2004

published in

Blood Journal

Research

keywords

Antineoplastic Agents, Alkylating
Graft Rejection
Immunosuppressive Agents
Melphalan
Vidarabine

Identity

Scopus Document Identifier

2542450948

PubMed ID

15155474

Additional Document Info

has global citation frequency

6

volume

103

issue

11